Edition:
India

Oxford Immunotec Global PLC (OXFD.OQ)

OXFD.OQ on NASDAQ Stock Exchange Global Market

11.61USD
2:29am IST
Change (% chg)

$-0.03 (-0.26%)
Prev Close
$11.64
Open
$11.68
Day's High
$11.68
Day's Low
$11.42
Volume
36,143
Avg. Vol
44,976
52-wk High
$19.50
52-wk Low
$10.85

Select another date:

Mon, Jan 8 2018

BRIEF-Oxford Immunotec Announces Preliminary Revenue For Q4

* FY2017 REVENUE VIEW $104.1 MILLION -- THOMSON REUTERS I/B/E/S

BRIEF-Oxford Immunotec And Qiagen Reached A Settlement In Lawsuit

* OXFORD IMMUNOTEC GLOBAL - CO, QIAGEN REACHED A SETTLEMENT IN LAWSUIT IN U.S. COURT ALLEGING PATENT INFRINGEMENT IN RELATION TO QIAGEN'S PRODUCTS

BRIEF-Oxford Immunotec Global Plc says unit entered into a 2nd amendment to purchase agreement with Mabtech AB​

* Oxford Immunotec Global Plc - ‍on Nov 17, unit entered into a second amendment to purchase agreement with Mabtech AB​

BRIEF-Oxford Immunotec Global Q3 loss per share $0.70

* Oxford Immunotec reports third quarter 2017 financial results

BRIEF-Oxford Immunotec announces update in patent infringement litigation

* Oxford Immunotec announces update in patent infringement litigation

BRIEF-Oxford Immunotec updates on amendment to supply agreement with StemCell Technologies ​

* Oxford Immunotec Global PLC - ‍on Sept 1 unit entered into second amendment to supply agreement with StemCell Technologies Canada f/k/a StemCell Technologies ​

BRIEF-Oxford Immunotec appoints Stefan Linn as COO

* Oxford Immunotec appoints Stefan Linn as chief operating officer Source text for Eikon: Further company coverage:

BRIEF-Oxford Immunotec Global Plc announces pricing of underwritten public offering of ordinary shares

* Oxford Immunotec Global Plc announces pricing of underwritten public offering of ordinary shares

BRIEF-Oxford Immunotec Global announces agreement to sell 2.5 mln ordinary shares

* Oxford Immunotec Global Plc announces agreement to sell 2,500,000 ordinary shares

BRIEF-Oxford Immunotec Q2 loss per share $0.74

* Oxford immunotec reports second quarter 2017 financial results

Select another date: